CD274 and neoplasm: Although PD-L1 expression in tumor tissues prior to treatment correlates with clinical outcomes, the density of tumor-infiltrating lymphocytes (TILs) in the invaded margin of the tumor may better predict the response to anti-PD-1/PD-L1 therapy [8].